Sarlósejtes vérszegénység: vizsgálatok itt: Egyesült Államok

In Egyesült Államok 133 Also abroad 204

133 trials · From ClinicalTrials.gov, checked 2026. november 15.. Ask the study team whether a trial fits you.

1. fázisTaking people
A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
Where
Atlanta, Augusta, Birmingham, Chicago, Cincinnati, Durham, Greenville, Indianapolis, New York, Pittsburgh, San Francisco
Életkor
18 év and over
People
24
Run by
Disc Medicine, Inc
See details and how to joinNCT07187973
No phaseCsak meghívásos
Blood Collection for Research Related to Certain Diseases Involving Blood Vessels
Where
Bethesda, Fairfax
Életkor
18 év to 100 év
People
2000
Run by
National Heart, Lung, and Blood Institute (NHLBI)
See details and how to joinNCT00047996
No phaseTaking people
Natural History of Sickle Cell Disease
Where
Bethesda, Washington D.C.
Életkor
2 év to 90 év
People
3500
Run by
National Heart, Lung, and Blood Institute (NHLBI)
See details and how to joinNCT00081523
2. fázisTaking people
Haploidentical Donor Hematopoietic Cell Transplant for Sickle Cell Disease
Where
Memphis
Életkor
Up to 22 év
People
45
Run by
St. Jude Children's Research Hospital
See details and how to joinNCT07616154
No phaseTaking people
Genotype -Phenotype Correlation of PKLR Variants With Pyruvate Kinase, 2,3-Diphosphglycerate and Adenosine Triphosphate Activities in Red Blood Cells of People With Sickle Cell Disease
Where
Bethesda
Életkor
18 év to 80 év
People
800
Run by
National Heart, Lung, and Blood Institute (NHLBI)
See details and how to joinNCT03685721
3. fázisTaking people
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
Where
Augusta, Baltimore, Birmingham, Chicago, Easton, Flowood, Greenville, Houston, Jacksonville, Louisville, Orange, Philadelphia, Riverdale, The Bronx, Washington D.C., Winston-Salem
Életkor
12 év to 100 év
People
354 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT06439082
No phaseNot yet taking people in Egyesült Államok
Mechanisms Within the Autonomic Nervous SysTEm undeRlying MusIc Therapy's aNalgesic Effects in Sickle Cell Disease (MASTERMIND)
Where
Cleveland
Életkor
18 év and over
People
10
Run by
University Hospitals Cleveland Medical Center
See details and how to joinNCT07928089
No phaseTaking people
HPC Offered for PRESERVE Expansion
Where
Birmingham, Columbus, Detroit, Duarte, Nashville
Életkor
12 év to 80 év
People
10
Run by
Ossium Health, Inc.
See details and how to joinNCT07145411
1. fázisTaking people
Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease
Where
Bethesda
Életkor
18 év to 65 év
People
35
Run by
National Heart, Lung, and Blood Institute (NHLBI)
See details and how to joinNCT05904093
4. fázisTaking people
Clinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females With Sickle Cell Disease
Where
Atlanta, Philadelphia
Életkor
18 év to 50 év
People
65
Run by
University of Pennsylvania
See details and how to joinNCT06665997
1. fázisNot yet taking people in Egyesült Államok
Buprenorphine for the Management of Pain in Children With Sickle Cell Disease
Where
Boston
Életkor
12 év to 22 év
People
25
Run by
Natasha Archer
See details and how to joinNCT07799571
2. fázisTaking people
Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
Where
Atlanta, Bethesda, Boston, Columbus, Flowood, Hollywood, Houston, Jamaica, Little Rock, Minneapolis, New York, Orange, Richmond, The Bronx
Életkor
18 év and over
People
63 worldwide
Run by
CSL Behring
See details and how to joinNCT07224360 · EU 2025-521154-42-00
No phaseNot yet taking people in Egyesült Államok
Data Collection For Patients With Sickle Cell Disease
Where
Houston
Életkor
18 év and over
People
500
Run by
M.D. Anderson Cancer Center
See details and how to joinNCT07911618
No phaseNot yet taking people in Egyesült Államok
Hypoxic Red Blood Cells in Sickle Cell Anemia
Where
Atlanta, Baltimore, Chicago, Farmington, Pittsburgh
Életkor
7 év and over
People
48
Run by
Hemanext
See details and how to joinNCT06743113
No phaseNot yet taking people in Egyesült Államok
Focused Ultrasound Neuromodulation for Chronic Pain
Where
Minneapolis
Életkor
18 év and over
People
80
Run by
University of Minnesota
See details and how to joinNCT07910396
3. fázisTaking people
A Study to Investigate the Effect of Mitapivat on Transfusion Burden in Subjects With Sickle Cell Disease (SCD)
Where
Flowood, Grand Rapids, Houston, Indianapolis, New York
Életkor
12 év and over
People
159 worldwide
Run by
Agios Pharmaceuticals, Inc.
See details and how to joinNCT07656415 · EU 2026-526778-18-00
1/2. fázisTaking people
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Where
Birmingham, Boston, Charlotte, Greenville, Houston, Miami, New York, Philadelphia, Providence
Életkor
12 év to 55 év
People
161 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT06546670 · EU 2024-515696-35-00
No phaseTaking people
Blood Sampling for Research Related to Sickle Cell Disease
Where
Bethesda
Életkor
18 év to 100 év
People
250
Run by
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
See details and how to joinNCT00542230
1/2. fázisTaking people
Repeat Peripheral Blood Stem Cell Transplantation for Patients With Sickle Cell Disease and Falling Donor Myeloid Chimerism Levels
Where
Bethesda
Életkor
2 év to 80 év
People
32
Run by
National Heart, Lung, and Blood Institute (NHLBI)
See details and how to joinNCT04008368
2. fázisTaking people
AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
Where
Valhalla
Életkor
1 nap to 30 év
People
20
Run by
Mitchell Cairo
See details and how to joinNCT04099966
No phaseTaking people
Observational Study to Deeply Phenotype Major Organs in Sickle Cell Disease After Curative Therapies
Where
Bethesda
Életkor
18 év to 100 év
People
200
Run by
National Heart, Lung, and Blood Institute (NHLBI)
See details and how to joinNCT05213572
No phaseTaking people
Trans-auricular Nerve Stimulation as an Innovative Approach to the Treatment of Pain in Pediatric Patients Suffering From Sickle Cell Disease
Where
Atlanta
Életkor
7 év to 18 év
People
20
Run by
Emory University
See details and how to joinNCT07090668
1. fázisTaking people
Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease
Where
Bethesda
Életkor
18 év to 90 év
People
25
Run by
National Heart, Lung, and Blood Institute (NHLBI)
See details and how to joinNCT07566494
1. fázisTaking people
Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Sickle Cell Disease
Where
Boston
Életkor
13 év to 35 év
People
5
Run by
Daniel Bauer
See details and how to joinNCT07708350
1/2. fázisTaking people
Transplantation of Clustered Regularly Interspaced Short Palindromic Repeats Modified Hematopoietic Progenitor Stem Cells (CRISPR_SCD001) in Patients With Severe Sickle Cell Disease
Where
Davis, Los Angeles, Oakland
Életkor
12 év to 35 év
People
9
Run by
Mark Walters, MD
See details and how to joinNCT04774536